ZNF202

Across TCGA pan-cancer cohorts, ZNF202 Mutation is linked to patient survival in 10 of 34 cancer types, making it a survival-associated ZNF202 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher ZNF202 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF202 expression acts as an unfavorable survival marker.

LUSC, LUAD, and LGG are the cancer types where ZNF202 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.398	0.780	<.001	27	view →
LUAD	OS	Median	II,III,IV	0.111	0.750	<.001	18	view →
LGG	DFS	Median	All	0.143	0.834	<.001	14	view →
CESC	OS	Median	II,III,IV	0.047	0.830	<.001	12	view →
STAD	OS	Median	All	0.250	0.729	.034	12	view →
COAD	OS	Median	II,III,IV	0.001	0.860	<.001	9	view →
SKCM	OS	Median	All	0.215	0.781	<.001	7	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
ESCA	DFS	Median	All	0.133	0.536	.005	6	view →
LIHC	DFS	Median	II,III,IV	0.100	0.431	.005	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

ZNF202–LUSC (OS)

Open the LUSC breakdown →